Tat-HSPE1 suppresses clear cell renal cell carcinoma growth through lysosome-dependent cell death
Lin Zhang1, Weiyuan Li1,2, Min Liu3
1Tongren Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of kidney cancer; however, first-line therapeutic agents show limited efficacy in patients with advanced disease. Bioactive peptides have emerged as promising candidates for anticancer therapy. In this study, a novel peptide derived from Heat Shock Protein Family E Member 1 (HSPE1) was identified by peptidomics analysis of human ccRCC tissues and paired adjacent normal tissues. We then engineered a novel fusion peptide designated Tat-HSPE1. Tat-HSPE1 selectively induced in vitro cell death in ccRCC cells while exerting minimal cytotoxic effects on normal epithelial cells and other tumor cell types. Analyses on the potential mechanism revealed that Tat-HSPE1 induced DNA damage, caspase-independent apoptosis, and lysosomal membrane permeabilization. Following cellular uptake, Tat-HSPE1 preferentially accumulated within the nucleolar compartment, where it interacted with CTTNBP2NL, a newly identified negative regulator of autophagy. This interaction promoted the translocation of CTTNBP2NL from the nucleus to the cytoplasm, facilitating the activation of autophagic processes. Furthermore, in vivo experiments demonstrated that Tat-HSPE1 significantly suppressed xenograft tumor growth. These findings indicate that Tat-HSPE1 represents a promising peptide-based therapeutic candidate for the treatment of ccRCC.
Insights
A novel peptide, Tat-HSPE1, derived from Heat Shock Protein Family E Member 1 (HSPE1), shows promise for treating clear cell renal cell carcinoma (ccRCC). It selectively kills ccRCC cells by inducing DNA damage and activating autophagy, while suppressing tumor growth in vivo.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Clear cell renal cell carcinoma (ccRCC) is the most common kidney cancer subtype.
- Current first-line treatments have limited efficacy in advanced ccRCC.
- Bioactive peptides are emerging as potential anticancer therapeutics.
Purpose of the Study:
- To identify and characterize novel peptide therapeutics for ccRCC.
- To investigate the therapeutic potential of a fusion peptide derived from Heat Shock Protein Family E Member 1 (HSPE1), designated Tat-HSPE1.
- To elucidate the molecular mechanisms underlying Tat-HSPE1's anticancer activity.
Main Methods:
- Peptidomics analysis of ccRCC tissues and adjacent normal tissues.
- In vitro cell death assays on ccRCC and normal cells.
- Mechanism of action studies including DNA damage, apoptosis, and lysosomal membrane permeabilization assays.
- Confocal microscopy to track peptide localization and protein interactions.
- In vivo xenograft tumor growth suppression studies.
Main Results:
- A novel peptide derived from HSPE1 was identified.
- Engineered Tat-HSPE1 selectively induced cell death in ccRCC cells with minimal toxicity to normal cells.
- Tat-HSPE1 induced DNA damage, caspase-independent apoptosis, and lysosomal membrane permeabilization.
- Tat-HSPE1 accumulated in the nucleolus, interacted with CTTNBP2NL, and promoted autophagy.
- Tat-HSPE1 significantly suppressed ccRCC xenograft tumor growth in vivo.
Conclusions:
- Tat-HSPE1 demonstrates selective cytotoxicity against ccRCC cells.
- Tat-HSPE1 exerts its effects through DNA damage, apoptosis, and autophagy modulation.
- Tat-HSPE1 shows significant therapeutic potential for ccRCC treatment.
Related Concept Videos
Replicative Cell Senescence
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

